Importance:
Limited information exists about the epidemiology, recognition, management, and outcomes of patients with the acute respiratory distress syndrome (ARDS).
Objectives:
To evaluate intensive care unit (ICU) incidence and outcome of ARDS and to assess clinician recognition, ventilation management, and use of adjuncts-for example prone positioning-in routine clinical practice for patients fulfilling the ARDS Berlin Definition.
Design, Setting, And Participants:
The Large Observational Study to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG SAFE) was an international, multicenter, prospective cohort study of patients undergoing invasive or noninvasive ventilation, conducted during 4 consecutive weeks in the winter of 2014 in a convenience sample of 459 ICUs from 50 countries across 5 continents.
Exposures:
Acute respiratory distress syndrome.
Main Outcomes And Measures:
The primary outcome was ICU incidence of ARDS. Secondary outcomes included assessment of clinician recognition of ARDS, the application of ventilatory management, the use of adjunctive interventions in routine clinical practice, and clinical outcomes from ARDS.
Results:
Of 29,144 patients admitted to participating ICUs, 3022 (10.4%) fulfilled ARDS criteria. Of these, 2377 patients developed ARDS in the first 48 hours and whose respiratory failure was managed with invasive mechanical ventilation. The period prevalence of mild ARDS was 30.0% (95% CI, 28.2%-31.9%); of moderate ARDS, 46.6% (95% CI, 44.5%-48.6%); and of severe ARDS, 23.4% (95% CI, 21.7%-25.2%). ARDS represented 0.42 cases per ICU bed over 4 weeks and represented 10.4% (95% CI, 10.0%-10.7%) of ICU admissions and 23.4% of patients requiring mechanical ventilation. Clinical recognition of ARDS ranged from 51.3% (95% CI, 47.5%-55.0%) in mild to 78.5% (95% CI, 74.8%-81.8%) in severe ARDS. Less than two-thirds of patients with ARDS received a tidal volume 8 of mL/kg or less of predicted body weight. Plateau pressure was measured in 40.1% (95% CI, 38.2-42.1), whereas 82.6% (95% CI, 81.0%-84.1%) received a positive end-expository pressure (PEEP) of less than 12 cm H2O. Prone positioning was used in 16.3% (95% CI, 13.7%-19.2%) of patients with severe ARDS. Clinician recognition of ARDS was associated with higher PEEP, greater use of neuromuscular blockade, and prone positioning. Hospital mortality was 34.9% (95% CI, 31.4%-38.5%) for those with mild, 40.3% (95% CI, 37.4%-43.3%) for those with moderate, and 46.1% (95% CI, 41.9%-50.4%) for those with severe ARDS.
Conclusions And Relevance:
Among ICUs in 50 countries, the period prevalence of ARDS was 10.4% of ICU admissions. This syndrome appeared to be underrecognized and undertreated and associated with a high mortality rate. These findings indicate the potential for improvement in the management of patients with ARDS.
Trial Registration:
clinicaltrials.gov Identifier: NCT02010073.
Citing Articles
Subphenotyping prone position responders with machine learning.
Fosset M, von Wedel D, Redaelli S, Talmor D, Molinari N, Josse J
Crit Care. 2025; 29(1):116.
PMID: 40087660
DOI: 10.1186/s13054-025-05340-8.
Total bilirubin as a marker for hemolysis and outcome in patients with severe ARDS treated with veno-venous ECMO.
Bunger V, Menk M, Hunsicker O, Krannich A, Balzer F, Spies C
BMC Anesthesiol. 2025; 25(1):121.
PMID: 40082753
PMC: 11905513.
DOI: 10.1186/s12871-025-02988-1.
Screening of mitochondrial-related biomarkers connected with immune infiltration for acute respiratory distress syndrome through WGCNA and machine learning.
Sun W, Tu S
Medicine (Baltimore). 2025; 104(10):e41497.
PMID: 40068062
PMC: 11903030.
DOI: 10.1097/MD.0000000000041497.
Progress of tanshinone IIA against respiratory diseases: therapeutic targets and potential mechanisms.
Ding Z, Deng Y, Luo H, Liu C, Yang M, Xue H
Front Pharmacol. 2025; 16:1505672.
PMID: 40066338
PMC: 11891354.
DOI: 10.3389/fphar.2025.1505672.
Dexmedetomidine administration is associated with reduced mortality in patients with sepsis-induced acute respiratory distress syndrome: a retrospective study.
Zhang J, Jia Z, Zhang Y, Tao Z
BMC Anesthesiol. 2025; 25(1):118.
PMID: 40065234
PMC: 11892135.
DOI: 10.1186/s12871-025-02961-y.
Remimazolam mitigates oxidative stress response in patients undergoing one-lung ventilation.
Li S, Sana S, Wang D
Front Surg. 2025; 12:1456827.
PMID: 40060219
PMC: 11885262.
DOI: 10.3389/fsurg.2025.1456827.
Advances in acute respiratory distress syndrome: focusing on heterogeneity, pathophysiology, and therapeutic strategies.
Ma W, Tang S, Yao P, Zhou T, Niu Q, Liu P
Signal Transduct Target Ther. 2025; 10(1):75.
PMID: 40050633
PMC: 11885678.
DOI: 10.1038/s41392-025-02127-9.
Neutrophil-derived heparin-binding protein increases endothelial permeability in acute lung injury by promoting TRIM21 and the ubiquitination of P65.
Zhang J, Cao Y, Shu W, Dong S, Sun Y, Ma X
Cell Biol Toxicol. 2025; 41(1):55.
PMID: 40045003
PMC: 11882632.
DOI: 10.1007/s10565-025-10005-x.
Predictive validity of the sequential organ failure assessment score for mortality in patients with acute respiratory distress syndrome in Vietnam.
Dao C, Dang T, Luong C, Manabe T, Nguyen M, Pham D
Sci Rep. 2025; 15(1):7406.
PMID: 40033012
PMC: 11876689.
DOI: 10.1038/s41598-025-92199-y.
Macrophage pyroptosis and its crucial role in ALI/ARDS.
Cai Y, Shang L, Zhou F, Zhang M, Li J, Wang S
Front Immunol. 2025; 16:1530849.
PMID: 40028334
PMC: 11867949.
DOI: 10.3389/fimmu.2025.1530849.
Inhibition of acute lung inflammation by a neuroimmune circuit induced by vagal nerve stimulation.
Murray K, Cremin M, Tay E, Sanchez K, Schreiber S, Brust-Mascher I
bioRxiv. 2025; .
PMID: 40027796
PMC: 11870408.
DOI: 10.1101/2025.02.12.637880.
Machine learning-based identification of efficient and restrictive physiological subphenotypes in acute respiratory distress syndrome.
Meza-Fuentes G, Delgado I, Barbe M, Sanchez-Barraza I, Retamal M, Lopez R
Intensive Care Med Exp. 2025; 13(1):29.
PMID: 40024962
PMC: 11872963.
DOI: 10.1186/s40635-025-00737-9.
The implementation gap in critical care: From nutrition to ventilation.
Azamfirei R
J Crit Care Med (Targu Mures). 2025; 11(1):3-4.
PMID: 40017471
PMC: 11864064.
DOI: 10.2478/jccm-2025-0011.
Promotion of NLRP3 autophagosome degradation by PV-K nanodevice for protection against macrophage pyroptosis-mediated lung injury.
Fan Y, Mei J, Shen Y, Gao Y, Zhao L, Meng S
J Nanobiotechnology. 2025; 23(1):148.
PMID: 40016743
PMC: 11866711.
DOI: 10.1186/s12951-025-03219-y.
Soluble E-cadherin contributes to inflammation in acute lung injury via VEGF/VEGFR2 signaling.
Yao L, Chen Z, Gan S, Fu C, Xie Z, Zhang H
Cell Commun Signal. 2025; 23(1):113.
PMID: 40011876
PMC: 11866821.
DOI: 10.1186/s12964-025-02110-5.
Electrical impedance tomography for PEEP titration in ARDS patients: a systematic review and meta-analysis.
Sanchez-Piedra C, Rodriguez-Ortiz-de-Salazar B, Roca O, Prado-Galbarro F, Perestelo-Perez L, Sanchez-Gomez L
J Clin Monit Comput. 2025; .
PMID: 40011398
DOI: 10.1007/s10877-025-01266-2.
Predictive value of the monocyte count for determining the risk of postoperative moderate-to-severe ARDS in patients undergoing one-lung ventilation during radical treatment of esophageal cancer.
Zhang F, Lu S, Wang G, Xu H, Huang D, Li X
Front Med (Lausanne). 2025; 12:1510788.
PMID: 40007585
PMC: 11850344.
DOI: 10.3389/fmed.2025.1510788.
sRAGE as a Prognostic Biomarker in ARDS: Insights from a Clinical Cohort Study.
Andrijevic A, Batranovic U, Nedeljkov D, Gavrilovic S, Carapic V, Milic S
Medicina (Kaunas). 2025; 61(2).
PMID: 40005345
PMC: 11857119.
DOI: 10.3390/medicina61020229.
Mouse mesenchymal stem cell-derived exosomal miR-205-5p modulates LPS-induced macrophage polarization and alleviates lung injury by regulating the USP7/FOXM1 axis.
Feng Y, Tang M, Li H, Yao S, Li B
Drug Deliv Transl Res. 2025; .
PMID: 40000557
DOI: 10.1007/s13346-025-01813-z.
Mechanical power is not associated with mortality in COVID-19 mechanically ventilated patients.
Barbeta E, Barreiros C, Forin E, Guzzardella A, Motos A, Fernandez-Barat L
Ann Intensive Care. 2025; 15(1):27.
PMID: 39998751
PMC: 11861844.
DOI: 10.1186/s13613-025-01430-6.